Matches in Wikidata for { <http://www.wikidata.org/entity/Q93328822> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q93328822 description "clinical trial" @default.
- Q93328822 description "ensayo clínico" @default.
- Q93328822 description "ensayu clínicu" @default.
- Q93328822 description "klinisch onderzoek" @default.
- Q93328822 description "клінічне випробування" @default.
- Q93328822 description "կլինիկական փորձարկում" @default.
- Q93328822 description "临床试验" @default.
- Q93328822 name "Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer" @default.
- Q93328822 name "Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer" @default.
- Q93328822 type Item @default.
- Q93328822 label "Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer" @default.
- Q93328822 label "Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer" @default.
- Q93328822 prefLabel "Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer" @default.
- Q93328822 prefLabel "Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer" @default.
- Q93328822 P1132 Q93328822-451DAEF2-146B-4A80-9948-762DB064662A @default.
- Q93328822 P1476 Q93328822-7D9D1FBB-4FF0-4A40-B575-776F2DDAA4A7 @default.
- Q93328822 P2899 Q93328822-B9287C90-29E7-4E39-8932-6EDECF18F4D1 @default.
- Q93328822 P3098 Q93328822-50761C91-6B21-4D3F-BD51-06518F1AFC6A @default.
- Q93328822 P31 Q93328822-64D61FBF-3A50-484B-AEAB-6964ADE59FE9 @default.
- Q93328822 P4844 Q93328822-7A10F229-A2EE-4DB7-96F6-86DE9FE296C6 @default.
- Q93328822 P580 Q93328822-FEE3BE3E-988B-4D8F-B263-9AE827CD5520 @default.
- Q93328822 P582 Q93328822-7DE5D80A-B0CD-4A1A-AE03-9CA9AD4D864E @default.
- Q93328822 P6099 Q93328822-5F2829AE-D42B-475E-9397-3670B85C60E5 @default.
- Q93328822 P767 Q93328822-AF9471F8-3CE3-43AA-981C-C343E8FAC90F @default.
- Q93328822 P8005 Q93328822-709CB0E1-C408-4688-84F6-522A5F267420 @default.
- Q93328822 P8363 Q93328822-58BFA6BE-B470-40B8-B488-AA17F91AE8C9 @default.
- Q93328822 P1132 "+30" @default.
- Q93328822 P1476 "Induction Immunotherapy to Promote Immunologic Priming and Enhanced Response to Neoadjuvant Pembrolizumab + Chemotherapy in Triple Negative Breast Cancer (TNBC)" @default.
- Q93328822 P2899 "+18" @default.
- Q93328822 P3098 "NCT04373031" @default.
- Q93328822 P31 Q30612 @default.
- Q93328822 P4844 Q13896859 @default.
- Q93328822 P580 "2020-07-15T00:00:00Z" @default.
- Q93328822 P582 "2024-06-01T00:00:00Z" @default.
- Q93328822 P6099 Q42824440 @default.
- Q93328822 P767 Q58219685 @default.
- Q93328822 P8005 Q76649614 @default.
- Q93328822 P8363 Q78089383 @default.